Vaccine News and Research

Latest Vaccine News and Research

Adults and children have similar neutralizing antibody responses to SARS-CoV-2 infection

Adults and children have similar neutralizing antibody responses to SARS-CoV-2 infection

New app and lab kit transform a smartphone into COVID-19 / flu detection system

New app and lab kit transform a smartphone into COVID-19 / flu detection system

Intranasal vaccine with nanoparticles offers strong protection against influenza viruses

Intranasal vaccine with nanoparticles offers strong protection against influenza viruses

Mix-and-match of COVID-19 vaccine boosters found to be safe and effective

Mix-and-match of COVID-19 vaccine boosters found to be safe and effective

UK's most vulnerable will soon be able to access second ground-breaking antiviral

UK's most vulnerable will soon be able to access second ground-breaking antiviral

Studying the effect of COVID-19 mRNA vaccine on human lung carcinoma epithelial cells using Raman spectroscopy and imaging

Studying the effect of COVID-19 mRNA vaccine on human lung carcinoma epithelial cells using Raman spectroscopy and imaging

Novel “prime and spike” vaccine strategy leverages existing immunity generated by primary COVID-19 vaccination

Novel “prime and spike” vaccine strategy leverages existing immunity generated by primary COVID-19 vaccination

Study explores vaccine effectiveness against the SARS-CoV-2 Omicron variant in patients receiving hemodialysis

Study explores vaccine effectiveness against the SARS-CoV-2 Omicron variant in patients receiving hemodialysis

A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

Evidence on intra-host recombination of SARS-CoV-2 during superinfection by Alpha and Epsilon variants in USA

Evidence on intra-host recombination of SARS-CoV-2 during superinfection by Alpha and Epsilon variants in USA

Reduced neutralization against Omicron variant in fully immunized adolescents with BNT162b2 vaccine

Reduced neutralization against Omicron variant in fully immunized adolescents with BNT162b2 vaccine

In super-vaxxed Vermont, covid strikes — but packs far less punch

In super-vaxxed Vermont, covid strikes — but packs far less punch

Impact of the Omicron variant on disease severity and healthcare utilization

Impact of the Omicron variant on disease severity and healthcare utilization

Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

Potential therapy candidates for patients infected with the SARS-CoV-2 Omicron variant

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

Study demonstrates minimally invasive, aerosolized vaccine candidate to combat SARS-CoV-2

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

Exploring receptor-blocking conserved non-neutralizing antibodies for SARS-CoV-2 therapy

E406W mutation on SARS-CoV-2 RBD escapes monoclonal antibody cocktail-mediated neutralization

E406W mutation on SARS-CoV-2 RBD escapes monoclonal antibody cocktail-mediated neutralization

New data suggests that post-vaccination menstrual changes are short-lived

New data suggests that post-vaccination menstrual changes are short-lived

KHN’s ‘What the Health?’: Record ACA enrollment puts pressure on Congress

KHN’s ‘What the Health?’: Record ACA enrollment puts pressure on Congress

Scientists identify immunogens that can elicit antibody responses against multiple SARS-CoV-2 variants

Scientists identify immunogens that can elicit antibody responses against multiple SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.